Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Vaccine Adjuvants Market from 2024 to 2025?

There has been a robust growth in the vaccine adjuvants market in the recent years. The market, which valued at $1.89 billion in 2024, is expected to grow to $2.03 billion in 2025 with a compound annual growth rate (CAGR) of 7.6%. The surge in growth during the historic period is attributable to factors such as increased vaccine production, rise in pervasive diseases, government-backed initiatives and immunization programs, investment in research and development, and the international distribution of vaccines.

What Is the Projected Market Size of the Vaccine Adjuvants Market?

Expectations are high for robust expansion in the vaccine adjuvants market size in the upcoming years. It’s projected to climb to “$2.89 billion by 2029, with a compound annual growth rate (CAGR) of 9.2%. The anticipated growth during this forecasting phase is linked to readiness for pandemics, a broadening vaccine portfolio, worldwide immunization targets, combined efforts and alliances, and an emphasis on therapeutic vaccines. Key trends for the forecasting period include innovations in adjuvant technologies, a concentrated approach to boost immunogenicity, combination adjuvants for greater efficacy, the need for safer and better-tolerated adjuvants, and tailor-made vaccines and adjuvants.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

Who are the Major Competitors in the Vaccine Adjuvants Market Outlook?

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

What Is Fueling Growth in the Vaccine Adjuvants Market?

The escalating occurrence of contagious illnesses is anticipated to spur the expansion of the vaccine adjuvants market. Contagious diseases encompass infections triggered by viruses, bacteria, fungi, or parasites. Vaccines are employed to counter these ailments such as hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. For example, as per the 2022 data from the World Health Organization (WHO), an estimated 10.6 million individuals were infected with tuberculosis in 2021 worldwide, with 1.6 million fatalities and 1.5 million new cases of HIV infection in 2021 causing 650,000 deaths. Consequently, the increasing pervasiveness of infectious maladies will fuel the growth of the vaccine adjuvants market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

Which Vaccine Adjuvants Market Segments Are Growing the Fastest?

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Which Industry Trends Are Shaping the Future of the Vaccine Adjuvants Market?

Emerging trends in the vaccine adjuvants market are being dominated by product innovations. Businesses in this sector are leveraging novel solutions to solidify their market standing. An example of this occurred in December 2022, when Evonik Industries, a chemical manufacturing firm based in Germany, launched PhytoSquene, a plant-based squalene obtained from amaranth oil. This eco-friendly substitute to the conventional shark-derived squalene is crafted for utilization in vaccine adjuvants and several other pharmaceutical uses, boosting the effectiveness of vaccines by enhancing immune responses. The creation of PhytoSquene highlights the escalating focus on environmental sustainability within the pharmaceutical industry.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Which Countries Are Leading the Vaccine Adjuvants Market?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10121

This Report Delivers Insight On:

1. How big is the vaccine adjuvants market, and how is it changing globally?

2. Who are the major companies in the vaccine adjuvants market, and how are they performing?

3. What are the key opportunities and risks in the vaccine adjuvants market right now?

4. Which products or customer segments are growing the most in the vaccine adjuvants market?

5. What factors are helping or slowing down the growth of the vaccine adjuvants market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model